Dan Leonard
Stock Analyst at UBS
(2.39)
# 2,400
Out of 4,847 analysts
289
Total ratings
51.25%
Success rate
-6.78%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Upgrades: Buy | $1,530 → $1,350 | $1,166.46 | +15.73% | 9 | May 20, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $14 → $12 | $9.11 | +31.72% | 5 | May 13, 2025 | |
| TECH Bio-Techne | Maintains: Buy | $95 → $70 | $48.78 | +43.50% | 11 | May 9, 2025 | |
| BRKR Bruker | Maintains: Neutral | $57 → $45 | $37.40 | +20.32% | 11 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $255 → $185 | $142.78 | +29.57% | 14 | May 7, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $355 → $310 | $220.57 | +40.54% | 20 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $355 → $310 | $224.67 | +37.98% | 20 | May 2, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $70 | $45.79 | +52.87% | 9 | May 1, 2025 | |
| RVTY Revvity | Upgrades: Buy | $145 → $115 | $91.03 | +26.33% | 2 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $715 → $500 | $399.93 | +25.02% | 15 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $240 | $192.06 | +24.96% | 17 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $13.15 | +90.11% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 → $185 | $138.49 | +33.58% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $5.84 | +54.11% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $420 → $350 | $306.08 | +14.35% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $16 | $11.46 | +39.62% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $21.17 | +65.33% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $150 | $112.76 | +33.03% | 21 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $81.83 | +144.41% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $2.23 | +393.27% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $160.15 | -56.29% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $90 | $54.84 | +64.11% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $9.94 | -29.58% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $349.39 | -1.26% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $133.76 | +94.38% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $173.59 | -16.47% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $63.04 | +42.77% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $45.28 | +40.57% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $250.51 | +35.72% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $21.79 | +10.14% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $4.88 | +617.21% | 12 | Aug 14, 2019 |
Mettler-Toledo International
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,166.46
Upside: +15.73%
10x Genomics
May 13, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $9.11
Upside: +31.72%
Bio-Techne
May 9, 2025
Maintains: Buy
Price Target: $95 → $70
Current: $48.78
Upside: +43.50%
Bruker
May 8, 2025
Maintains: Neutral
Price Target: $57 → $45
Current: $37.40
Upside: +20.32%
IQVIA Holdings
May 7, 2025
Maintains: Buy
Price Target: $255 → $185
Current: $142.78
Upside: +29.57%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $220.57
Upside: +40.54%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $224.67
Upside: +37.98%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $45.79
Upside: +52.87%
Revvity
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $91.03
Upside: +26.33%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $715 → $500
Current: $399.93
Upside: +25.02%
Apr 23, 2025
Maintains: Buy
Price Target: $275 → $240
Current: $192.06
Upside: +24.96%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $13.15
Upside: +90.11%
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $138.49
Upside: +33.58%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $5.84
Upside: +54.11%
Sep 27, 2024
Downgrades: Neutral
Price Target: $420 → $350
Current: $306.08
Upside: +14.35%
Sep 27, 2024
Upgrades: Buy
Price Target: $16
Current: $11.46
Upside: +39.62%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $21.17
Upside: +65.33%
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $112.76
Upside: +33.03%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $81.83
Upside: +144.41%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $2.23
Upside: +393.27%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $160.15
Upside: -56.29%
Aug 2, 2023
Maintains: Neutral
Price Target: $75 → $90
Current: $54.84
Upside: +64.11%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $9.94
Upside: -29.58%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $349.39
Upside: -1.26%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $133.76
Upside: +94.38%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $173.59
Upside: -16.47%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $63.04
Upside: +42.77%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $45.28
Upside: +40.57%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $250.51
Upside: +35.72%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $21.79
Upside: +10.14%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $4.88
Upside: +617.21%